Gallium dotatoc ga-68 - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic sources for gallium dotatoc ga-68 and what is the scope of freedom to operate?
Gallium dotatoc ga-68
is the generic ingredient in one branded drug marketed by Uihc Pet Imaging and is included in one NDA. Additional information is available in the individual branded drug profile pages.One supplier is listed for this compound.
Summary for gallium dotatoc ga-68
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 5 |
DailyMed Link: | gallium dotatoc ga-68 at DailyMed |
Recent Clinical Trials for gallium dotatoc ga-68
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
M.D. Anderson Cancer Center | Early Phase 1 |
National Cancer Institute (NCI) | Early Phase 1 |
NCM USA | Phase 3 |
US Patents and Regulatory Information for gallium dotatoc ga-68
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Uihc Pet Imaging | GALLIUM DOTATOC GA 68 | gallium dotatoc ga-68 | SOLUTION;INTRAVENOUS | 210828-001 | Aug 21, 2019 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Uihc Pet Imaging | GALLIUM DOTATOC GA 68 | gallium dotatoc ga-68 | SOLUTION;INTRAVENOUS | 210828-001 | Aug 21, 2019 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |